Published : Jun-2018
No. of Pages : 62
1 Table of Contents 2
1.1 List of Tables 4
1.2 List of Figures 5
2 Introduction 6
2.1 Radiofrequency Catheters Overview 6
3 Products under Development 7
3.1 Radiofrequency Catheters - Pipeline Products by Stage of Development 7
3.2 Radiofrequency Catheters - Pipeline Products by Territory 8
3.3 Radiofrequency Catheters - Pipeline Products by Regulatory Path 9
3.4 Radiofrequency Catheters - Pipeline Products by Estimated Approval Date 10
3.5 Radiofrequency Catheters - Ongoing Clinical Trials 11
4 Radiofrequency Catheters - Pipeline Products under Development by Companies 12
4.1 Radiofrequency Catheters Companies - Pipeline Products by Stage of Development 12
4.2 Radiofrequency Catheters - Pipeline Products by Stage of Development 13
5 Radiofrequency Catheters Companies and Product Overview 14
5.1 Handok Inc Company Overview 14
5.1.1 Handok Inc Pipeline Products & Ongoing Clinical Trials Overview 14
5.2 Handok-Kalos Medical Company Overview 16
5.2.1 Handok-Kalos Medical Pipeline Products & Ongoing Clinical Trials Overview 16
5.3 Lifetech Scientific (Shenzhen) Co Ltd Company Overview 17
5.3.1 Lifetech Scientific (Shenzhen) Co Ltd Pipeline Products & Ongoing Clinical Trials Overview 17
5.4 Medtronic plc Company Overview 18
5.4.1 Medtronic plc Pipeline Products & Ongoing Clinical Trials Overview 18
5.5 MicroPort Scientific Corp Company Overview 26
5.5.1 MicroPort Scientific Corp Pipeline Products & Ongoing Clinical Trials Overview 26
5.6 Renal Dynamics, LLC Company Overview 27
5.6.1 Renal Dynamics, LLC Pipeline Products & Ongoing Clinical Trials Overview 27
5.7 St. Jude Medical LLC Company Overview 30
5.7.1 St. Jude Medical LLC Pipeline Products & Ongoing Clinical Trials Overview 30
5.8 Suzhou SyMap Medical Ltd Company Overview 31
5.8.1 Suzhou SyMap Medical Ltd Pipeline Products & Ongoing Clinical Trials Overview 31
5.9 Verve Medical, Inc. Company Overview 34
5.9.1 Verve Medical, Inc. Pipeline Products & Ongoing Clinical Trials Overview 34
6 Radiofrequency Catheters- Recent Developments 35
6.1 May 24, 2018: Medtronic Reports Fourth Quarter And Fiscal Year 2018 Financial Results 35
6.2 May 23, 2018: New Medtronic Data Show Significant Blood Pressure Lowering Effect of Renal Denervation in Patients Taking Anti-Hypertensive Medication 37
6.3 May 11, 2018: Terumo Appoints its U.S.-based Subsidiary's Associate as the Fifth Terumo Fellow 38
6.4 May 09, 2018: Upmc Pinnacle Participating In Groundbreaking Trial To Help Lower Blood Pressure 39
6.5 May 07, 2018: Medtronic Appoints Mike Weinstein As Senior Vice President Of Strategy 39
6.6 Apr 25, 2018: Xianjian Technology Receives the Most Attention from Institutional Investors 40
6.7 Apr 09, 2018: Medtronic Announces Renal Denervation Pivotal Trial for the Treatment of Hypertension 40
6.8 Apr 05, 2018: Dr. Laura Mauri to Join Medtronic as Vice President, Global Clinical Research & Analytics 41
6.9 Feb 08, 2018: Terumo Revises the Full-Year Results Forecast for FY 2017 42
6.10 Jan 30, 2018: Alex Gu Named Senior Vice President and President of Medtronic's Greater China Region 42
6.11 Jan 25, 2018: Terumo Announces Change of Directors and Executive Officers 43
6.12 Jan 07, 2018: LifeTech Scientific and Ally Bridge Group Form China-Global Medtech Investment and Operating Partnership 45
6.13 Dec 19, 2017: Bob White Named Executive Vice President and President of Medtronic's Minimally Invasive Therapies Group; Chris Lee to Assume Leadership of Medtronic's Asia Pacific Region 46
6.14 Dec 13, 2017: Terumo Constructs a New Building in Yamaguchi, Japan To Strengthen Production Operations in Interventional Systems 47
6.15 Nov 24, 2017: MicroPort EP's Contact Force Sensing RF Ablation Catheter Gains CFDA Green-Path 47
6.16 Nov 21, 2017: Medtronic Reports Second Quarter Financial Results 47
6.17 Nov 08, 2017: Medtronic Announces Preliminary Second Quarter Revenue 50
6.18 Nov 02, 2017: Medtronic Releases Fiscal Year 2017 Integrated Performance Report 51
6.19 Oct 06, 2017: Medtronic Provides Update on Impact from Hurricane Maria 52
6.20 Sep 26, 2017: MicroVention Celebrates Grand Opening of New Worldwide Innovation Center in Aliso Viejo, California 53
6.21 Aug 28, 2017: Medtronic Plans for Renal Denervation Pivotal Trial After New Study Shows Significant Blood Pressure Reductions 54
6.22 Aug 22, 2017: Medtronic Reports First Quarter Financial Results 56
7 Appendix 59
7.1 Methodology 59
7.2 About GlobalData 62
7.3 Contact Us 62
7.4 Disclaimer 62
1.1 List of Tables
Table 1: Radiofrequency Catheters - Pipeline Products by Stage of Development 7
Table 2: Radiofrequency Catheters - Pipeline Products by Territory 8
Table 3: Radiofrequency Catheters - Pipeline Products by Regulatory Path 9
Table 4: Radiofrequency Catheters - Pipeline Products by Estimated Approval Date 10
Table 5: Radiofrequency Catheters - Ongoing Clinical Trials 11
Table 6: Radiofrequency Catheters Companies - Pipeline Products by Stage of Development 12
Table 7: Radiofrequency Catheters - Pipeline Products by Stage of Development 13
Table 8: Handok Inc Pipeline Products & Ongoing Clinical Trials Overview 14
Table 9: 2nd Gen Renal Denervation System - Product Status 14
Table 10: 2nd Gen Renal Denervation System - Product Description 15
Table 11: 3rd Gen Renal Denervation System - Product Status 15
Table 12: 3rd Gen Renal Denervation System - Product Description 15
Table 13: Handok-Kalos Medical Pipeline Products & Ongoing Clinical Trials Overview 16
Table 14: DENEX - Product Status 16
Table 15: DENEX - Product Description 16
Table 16: Lifetech Scientific (Shenzhen) Co Ltd Pipeline Products & Ongoing Clinical Trials Overview 17
Table 17: Renal Denervation Catheter - Product Status 17
Table 18: Renal Denervation Catheter - Product Description 17
Table 19: Medtronic plc Pipeline Products & Ongoing Clinical Trials Overview 18
Table 20: Symplicity Renal Denervation System - Product Status 18
Table 21: Symplicity Renal Denervation System - Product Description 19
Table 22: Symplicity Spyral Renal Denervation Catheter - Product Status 19
Table 23: Symplicity Spyral Renal Denervation Catheter - Product Description 19
Table 24: Medtronic plc - Ongoing Clinical Trials Overview 20
Table 25: Symplicity Renal Denervation System - A Prospective, Multicenter, Randomized, Open-label, Feasibility, Safety and Efficacy Study of Renal Denervation in Patients with Chronic Heart Failure (CHF) 21
Table 26: Symplicity Renal Denervation System - Effects of Catheter Based Renal Sympathetic Denervation on Resistant Hypertension in End Stage Renal Disease in Korea 21
Table 27: Symplicity Renal Denervation System - Global Prospective Registry for Sympathetic Renal Denervation in Selected Indications Through 3 Years Registry 21
Table 28: Symplicity Renal Denervation System - Impact of Renal Artery Denervation in Patients with Chronic Heart Failure Compared with Sham Procedure 22
Table 29: Symplicity Renal Denervation System - Prairie Renal Denervation Study 22
Table 30: Symplicity Renal Denervation System - Renal Denervation in Treatment Resistant Hypertension 22
Table 31: Symplicity Renal Denervation System - Renal Sympathetic Denervation Restores Autonomic Imbalance and Prevents Atrial Fibrillation in Patients with Hypertensive Heart Disease: A Pilot Study 23
Table 32: Symplicity Renal Denervation System - Understanding the Mechanisms of Progressive Decrease In Blood Pressure After Renal Nerve Ablation 23
Table 33: Symplicity Spyral Renal Denervation Catheter - A Randomized Comparison of Ultrasound Based Versus Radiofrequency Based Catheter Ablation Techniques in Patients with Therapy Resistant Arterial Hypertension with Large Renal Arteries 24
Table 34: Symplicity Spyral Renal Denervation Catheter - Combined Treatment with Percutaneous Coronary Intervention and Renal Denervation in Hypertensive Patients with Acute Coronary Syndromes 24
Table 35: Symplicity Spyral Renal Denervation Catheter - Global Clinical Study of Renal Denervation with the Symplicity Spyral Multi-electrode Renal Denervation System in Patients with Uncontrolled Hypertension in the Absence of Antihypertensive Medications: SPYRAL HTN-OFF MED 24
Table 36: Symplicity Spyral Renal Denervation Catheter - Global Clinical Study of Renal Denervation with the Symplicity Spyral Multi-electrode Renal Denervation System in Patients with Uncontrolled Hypertension on Standard Medical Therapy: SPYRAL HTN-ON MED 25
Table 37: Symplicity Spyral Renal Denervation Catheter - Pivotal Study for the Assessment of Safety and Efficacy of Symplicity Spyral Renal Denervation System in Subjects with Hypertension 25
Table 38: Symplicity Spyral Renal Denervation Catheter - Renal Nerve Denervation in Patients with Hypertension and Paroxysmal and Persistent Atrial Fibrillation 25
Table 39: MicroPort Scientific Corp Pipeline Products & Ongoing Clinical Trials Overview 26
Table 40: FlashPoint Renal Artery RF Ablation Catheter - Product Status 26
Table 41: FlashPoint Renal Artery RF Ablation Catheter - Product Description 26
Table 42: Renal Dynamics, LLC Pipeline Products & Ongoing Clinical Trials Overview 27
Table 43: ReDy Renal Denervation System - Product Status 27
Table 44: ReDy Renal Denervation System - Product Description 27
Table 45: Renal Dynamics, LLC - Ongoing Clinical Trials Overview 28
Table 46: ReDy Renal Denervation System - A Prospective, Post-marketing, Single-arm, Open Label, Multi-center Clinical Study to Evaluate the Safety and Efficacy of the ReDy Renal Denervation System in the Treatment of Patients with Uncontrolled Hypertension 29
Table 47: St. Jude Medical LLC Pipeline Products & Ongoing Clinical Trials Overview 30
Table 48: Third Generation EnligHTN Renal Denervation System - Product Status 30
Table 49: Third Generation EnligHTN Renal Denervation System - Product Description 30
Table 50: Suzhou SyMap Medical Ltd Pipeline Products & Ongoing Clinical Trials Overview 31
Table 51: SyMapCath I Catheter - Product Status 31
Table 52: SyMapCath I Catheter - Product Description 31
Table 53: Suzhou SyMap Medical Ltd - Ongoing Clinical Trials Overview 32
Table 54: SyMapCath I Catheter - A Prospective, Multicenter, Single Blind, Randomized and Controlled Trial of Renal Sympathetic Denervation Using SyMapCath I Catheter and SYMPIONEER S1 Stimulator/Generator for the Treatment of Hypertension (SMART Trial) 33
Table 55: Verve Medical, Inc. Pipeline Products & Ongoing Clinical Trials Overview 34
Table 56: Verve Medical System - Product Status 34
Table 57: Verve Medical System - Product Description 34
Table 58: Glossary 61
1.2 List of Figures
Figure 1: Radiofrequency Catheters - Pipeline Products by Stage of Development 7
Figure 2: Radiofrequency Catheters - Pipeline Products by Territory 8
Figure 3: Radiofrequency Catheters - Pipeline Products by Regulatory Path 9
Figure 4: Radiofrequency Catheters - Pipeline Products by Estimated Approval Date 10
Figure 5: Radiofrequency Catheters - Ongoing Clinical Trials 11
